[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Beijing Airdoc Technology Co., Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":96},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,76],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100522869",false,"NCT06088225","Myopia Preventing With Distance-image Screen","Clinically Study the Ocular Axial Length and Sphere Equivalence Changes of Children With Distance-image Screen Usage for One Year","DIS","Inclusion Criteria:\n\n* (1) Must be 6\\~12 years old;\n* (2) Must be best corrected visual acuity \\\u003C logMAR: 0.1;\n* (3) Spherical Equivalence (SE) must be -1.00\\~ + 6.00 Diopter (D),\n* (4) Spherical Equivalence (SE) must have changed \\> 1.25 Diopter (D) in the recent 2 years;\n* (5) Must be astigmatism \\\u003C1.75 Diopter (D);\n* (6) Must be anisometropia \\\u003C1.75 Diopter(D).\n\nExclusion Criteria:\n\n* (1) Strabismus disease;\n* (2) Amblyopia disease;\n* (3) Cataract disease;\n* (4) Glaucoma disease;\n* (5) Severe dry eye disease;\n* (6) Cannot use distance-image screen for 12 month;\n* (7) Other severe diseases that would effect the use of distance-image screen.",true,"ALL","6 Years","12 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study is for testing the efficacy and safety of distance-image screens for preventing myopia in children for 12 month. Each subjects would be asked to paired test the ocular parameters between before and after 12-month distance-image screens.",[28],"Myopia, Progressive",[30],"Myopia; children","RECRUITING","2023-10-20",{"date":34,"type":35},"2023-10-24","ACTUAL",{"date":37,"type":35},"2022-10-01",{"date":39,"type":22},"2026-12-31",{"name":41,"class":42},"Beijing Airdoc Technology Co., Ltd.","INDUSTRY",1,{"id":45,"slug":4,"hasResults":10,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":16,"sex":17,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":23,"phases":55,"briefSummary":56,"conditions":57,"keywords":61,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":5},"100520665","NCT06059521","Software Refraction With Mobilerone Versus Retinoscopy","Randomized Controlled Study on Subjective Refraction by Software Eye Test Technology Versus Retinoscopy","SRMR","Inclusion Criteria:\n\n* • subject with ametropia on each eye ≤-12.00D\n\n  * subject with best corrected visual acuity ≥ 20\u002F25, no amblyopia\n  * subject with normal transparency of eyes\n  * subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations\n  * subject able to cooperate with the screen and the operator\n  * subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids\n  * non-diabetic subject\n  * non nystagmus subject\n  * non-strabismus subject\n  * subject who has not had eye surgery less than 1 year old\n\nExclusion Criteria:\n\n* • subject with a topography showing an anomaly (keratoconus type or other)\n\n  * subject with hyperopia or presbyopia\n  * subject with mild myopia ≥ -1.00D\n  * subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists","10 Years","46 Years",{"count":54,"type":22},120,[25],"Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.",[58,59,60],"Myopia","Myopia, Moderate","Astigmatism",[62,63,64,65,66,67],"software","refraction","subjective refraction","mobilerone","myopia","astigmatism","2023-09-21",{"date":70,"type":35},"2023-09-28",{"date":72,"type":35},"2023-07-15",{"date":74,"type":22},"2030-12-30",{"name":41,"class":42},{"id":77,"slug":4,"hasResults":10,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":10,"sex":17,"minAge":18,"maxAge":82,"enrollmentInfo":83,"targetDuration":4,"studyType":23,"phases":85,"briefSummary":86,"conditions":87,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":43},"100497416","NCT05756959","Myopia Control Combined PBM With Myopic Defocus Lens in Children","Myopia Control Combined PBM With Myopic Defocus Lens in Children: Double-blind RCT for 6 Month","Inclusion Criteria:\n\n* Informed consent by the supervision of the children\n* 6\\~13 years old (including both the 6 and 13)\n* SE range: -0.50\\~-5.50D\n* Astigmatism \\\u003C=2.00D\n* BCVA \\>=0.8\n* Anisometropia \\\u003C=1.50D\n* Confirmed to no use of other myopia control intervention\n\nExclusion Criteria:\n\n* Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential opitc abnormal and etc.)\n* Halo, glare, toutic, ADHD, psoriasis\n* Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction.\n* Squint, ocular lesion or acute imflammation.\n* Other myopia control interventions within recent 3 month such as atropine, device, orthokeratology, multi-focus soft lens, multi-function spectacles.","13 Years",{"count":84,"type":22},304,[25],"To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.",[28],"2023-03-07",{"date":90,"type":35},"2023-03-09",{"date":92,"type":35},"2022-12-12",{"date":94,"type":22},"2027-12-31",{"name":41,"class":42},""]